SPIMACO
الدوائيةTechnical Analysis & Signals
The pharmaceutical stock shows an upward trend with positive signals from technical indicators.
Technical Analysis
The pharmaceutical stock (2070.SR) is currently trading at 29.94 SAR, showing a clear upward trend. Technical indicators such as RSI at 61.0 and MACD Hist at 0.3043 indicate strength in momentum.
Support & Resistance Levels
The main support level is at 29.74 SAR, while resistance is near 30.22 SAR. The stock is expected to react to these levels in the upcoming sessions.
Volume Analysis
Volume analysis may show an increase in activity, reinforcing the upward trend. If trading volume continues to rise, it could support the stock's positive movement.
Fundamental Factors
The price-to-earnings (P/E) ratio is 27.7, indicating a relatively high valuation. Additionally, the absence of a dividend yield may affect the stock's attractiveness to investors.
Risk Factors
The company may face risks related to fluctuations in the Saudi market, along with any changes in government policies. It is important to monitor these factors to assess their impact on the stock's performance.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. The stock is expected to continue its upward trend, but investors should conduct their own research.
Automated analysis is based on historical data and technical indicators and may not reflect future market conditions.
Financial Fundamentals
Price Data
Price Chart - SPIMACO
2070Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Moderate TrendFinancial Summary
Valuation
- Market Cap
- 3.57B
- P/E Ratio
- 27.70
- P/B Ratio
- 2.30
- EPS (Earnings/Share)
- 1.08
Profitability
- Revenue
- 1.69B
- Net Income
- 128.73M
- Return on Equity (ROE)
- +10.00%
- Shares Outstanding
- 119.36M
Balance Sheet
- Total Assets
- N/A
- Total Debt
- 1.43B
- Debt/Equity
- 0.84
- Free Float %
- +79.2%
Dividends & Margins
- Dividend Yield
- 0.00%
- Dividend/Share
- 0.00
- Book Value
- 13.02
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
4 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2024 | 1.68B +1.6% | 24.54M +148.4% | 4.32B +11.3% | 1.51B +35.1% | 0.21 +148.8% |
| 2023 | 1.66B +16.4% | -50.73M +69.3% | 3.88B +1.3% | 1.12B +3.5% | -0.43 +68.8% |
| 2022 | 1.42B -2.6% | -165.13M -724.2% | 3.83B -13.6% | 1.08B -16.5% | -1.38 -727.3% |
| 2021 | 1.46B | 26.45M | 4.43B | 1.29B | 0.22 |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
Alawwal Capital sets 11 Saudi top picks in 2026
SPIMACO sets up subsidiary to manufacture biopharma products
SPIMACO expects upbeat performance to continue in Q4 2025
SPIMACO partners with Boston Oncology to locally manufacture 4 products
SPIMACO inks SAR 200M financing deal with SNB
SPIMACO inaugurates oncology, high-potent drug plant
United Securities issues Q4 2025 earnings forecasts
Key events to drive Saudi-listed firms' performance in Q4 2025
News source: Argaam (argaam.com)
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-03-26
Risk Assessment
Risk Factors
Average True Range 3.5% of stock price
Trading volume near or above average
P/E ratio 27.7
Debt-to-equity ratio 0.84
ADX indicator at 22
Stable fundamentals, low volatility, and good financial solvency
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is SPIMACO stock price today?
SPIMACO (2070) stock price today is 29.94 SAR, gaining by +0.13% compared to the previous session close. The 52-week price range is between 20.94 SAR and 31.66 SAR.
2 What is SPIMACO stock valuation?
The automated analysis signal for SPIMACO is "Buy" with 75% confidence. The P/E ratio is 27.7. The P/B ratio is 2.30.
3 Is SPIMACO Shariah-compliant?
Yes, SPIMACO (2070) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are SPIMACO dividend distributions?
No dividend payment data is currently available for SPIMACO. The company may not distribute dividends or the data has not been updated yet.
5 What is SPIMACO weekly performance?
SPIMACO performance over different time periods: weekly change +10.40%, monthly -1.12%, and year-to-date +14.45%. The stock is currently trading with a volume of 663,979 shares.
6 What is the target level for SPIMACO?
According to automated analysis for SPIMACO: Short-term target (1-2 weeks): 30.50 SAR. Medium-term target (1-3 months): 31.00 SAR. Support level: 29.74 SAR. Resistance level: 30.22 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.